Arega Pharma
0722.544.585 · rovalta.com · 20/09/2026
ACTIVE
Arega Pharma
Financial year 2025 · closed on 31/12/2025
Net result
6,4 M €
+57.6% YoY
Revenue
63,4 M €
+13.5% YoY
Equity
9,8 M €
-12.2% YoY
Workforce
53,3 ETP
+1.1% YoY
Overview
What does Arega Pharma do?
Arega Pharma is a Public limited company incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Mechelen. It employs on average 53,3 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0722.544.585
Incorporation
08/03/2019
Legal form
Public limited company
Registered office
Stationsstraat 55
2800 Mechelen · FlandreSee on map
2800 Mechelen · FlandreSee on map
Contributed capital
220 000,00 €
Latest accounts
31/12/2025
Average workforce
53,3 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods46389Wholesale of other food, including fish, crustaceans and molluscs46389Wholesale of other food, including fish, crustaceans and molluscs46442Wholesale of china and glassware and cleaning materials46442Wholesale of china and glassware and cleaning materials+4
Joint committees (2)
- 200
- 2000
Contacts
1 public detail availableLog in to view
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 63,4 M € | +13.5% | 55,8 M € | +9.2% | 51,2 M € | +4.2% | 49,1 M € | +10.0% | 44,6 M € | -20.3% | 56,0 M € |
| EBITDA | 9,0 M € | +77.0% | 5,1 M € | +42.0% | 3,6 M € | -5.5% | 3,8 M € | +33.8% | 2,8 M € | -14.2% | 3,3 M € |
| Operating result | 8,0 M € | +40.0% | 5,7 M € | +61.8% | 3,5 M € | +42.6% | 2,5 M € | -12.8% | 2,8 M € | +68.9% | 1,7 M € |
| Net result | 6,4 M € | +57.6% | 4,0 M € | +65.1% | 2,4 M € | +41.3% | 1,7 M € | -8.1% | 1,9 M € | +112% | 885,4 k € |
| Balance sheet | |||||||||||
| Equity | 9,8 M € | -12.2% | 11,2 M € | +56.5% | 7,1 M € | +52.0% | 4,7 M € | +58.3% | 3,0 M € | +173% | 1,1 M € |
| Total assets | 54,2 M € | +25.8% | 43,0 M € | +46.5% | 29,4 M € | +42.7% | 20,6 M € | +20.3% | 17,1 M € | -6.2% | 18,2 M € |
| Cash | 5,6 k € | – | – | – | 1,7 M € | +161% | 669,1 k € | ||||
| Debts | 43,4 M € | +38.8% | 31,3 M € | +45.2% | 21,5 M € | +41.5% | 15,2 M € | +8.3% | 14,1 M € | -17.9% | 17,1 M € |
| Other | |||||||||||
| Workforce | 53,3 ETP | +1.1% | 52,7 ETP | -3.8% | 54,8 ETP | +4.0% | 52,7 ETP | +4.4% | 50,5 ETP | +6.5% | 47,4 ETP |
Estimate
Indicative valuation
As an indication, this company is worth
between 50 M€ and 100 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 7 active · 10 ended
Active mandates
Active
Active
Active
Active
Active
Active
Active
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
ALCON● Active | 0429.184.121 |
Arega Health● Active | 0721.744.435 |
BUFFL● Active | 0688.975.459 |
Hydra● Active | 0801.606.515 |
Juno Topco● Active | 0783.484.935 |
Let's App● Active | 0752.709.706 |
Protostars● Active | 0649.435.388 |
Spectricity● Active | 0685.594.317 |
Vyntra Belgium● Active | 0838.618.151 |
Vyntra Holding● Active | 0783.560.852 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 08/03/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 22 months |
| Filing date | 13/07/2026 | 30/07/2025 | 13/08/2024 | 17/10/2023 | 06/10/2022 | 07/07/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 01/07/2024 | 15/07/2023 | 15/07/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
6 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 30/06/2026 | 13/07/2026 | Dutch | |
| Full model | 31/12/2024 | 30/06/2025 | 30/07/2025 | Dutch | |
| Full model | 31/12/2023 | 01/07/2024 | 13/08/2024 | Dutch | |
| Full model | 31/12/2022 | 15/07/2023 | 17/10/2023 | Dutch | |
| Full model | 31/12/2021 | 15/07/2022 | 06/10/2022 | Dutch | |
| Full model | 31/12/2020 | 30/06/2021 | 07/07/2021 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 50 M€ and 100 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 7 active · 10 ended
Active mandates
Active
Active
Active
Active
Active
Active
Active
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Other26/08/2026DIVERSEN
- Mandates12/08/2026ONTSLAGEN, BENOEMINGEN
- Mandates16/04/2026ONTSLAGEN - BENOEMINGEN
- Mandates16/04/2026ONTSLAGEN - BENOEMINGEN
- Restructuring08/08/2025KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring28/05/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Registered office10/03/2025ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
- Mandates21/02/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20256,4 M €↑
- 2024Annual accounts 20244,0 M €↑
- 2023Annual accounts 20232,4 M €↑
- 2022Annual accounts 20221,7 M €↓
- 2021Annual accounts 20211,9 M €↑
- 2020Annual accounts 2020885,4 k €
- 08/03/2019IncorporationPublic limited company